pharma · Moderately to Severely Active Rheumatologic Disease · Moderately to Severely Active Ulcerative Colitis · SYRE
Spyre Therapeutics
News and analysis for Spyre Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
Waltham, USA HQ
2023 Founded
110 Employees
Public company Type
SYRE · NYSE Ticker
Company details
- Status
- Public
- HQ
- Waltham, USA
- Founded
- 2023
- Employees
- 110
- Programs
- 8
- Drugs
- 1
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning Spyre Therapeutics — regulatory, clinical, and market coverage.
News and analysis for Spyre Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.